D. E. Shaw & Co., Inc. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2016. The put-call ratio across all filers is 1.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$15,000
-89.1%
73,331
-76.1%
0.00%
Q3 2018$138,000
-15.3%
307,024
-5.4%
0.00%
Q2 2018$163,000
-79.8%
324,401
-6.2%
0.00%
-100.0%
Q1 2018$806,000
+5.9%
345,985
+29.2%
0.00%0.0%
Q4 2017$761,000
+148.7%
267,731
+149.7%
0.00%
Q3 2017$306,000
+565.2%
107,209
+477.8%
0.00%
Q2 2017$46,000
-78.4%
18,554
-68.6%
0.00%
Q1 2017$213,000
-89.4%
59,000
-89.6%
0.00%
-100.0%
Q4 2016$2,001,000
-55.6%
565,243
-49.3%
0.00%
-62.5%
Q3 2016$4,507,000
+1443.5%
1,115,431
+1578.9%
0.01%
+700.0%
Q2 2016$292,000
-80.2%
66,439
-29.5%
0.00%
-50.0%
Q4 2015$1,477,000
-16.0%
94,220
+35.2%
0.00%
-33.3%
Q2 2015$1,758,000
-40.9%
69,697
-34.7%
0.00%
-40.0%
Q1 2015$2,975,000
-38.3%
106,752
-59.6%
0.01%
-28.6%
Q4 2014$4,823,000
+20.9%
264,283
-14.1%
0.01%
+40.0%
Q3 2014$3,990,000
+21.1%
307,839
+52.5%
0.01%
+25.0%
Q2 2014$3,295,000
+8.2%
201,922
+17.2%
0.00%
-20.0%
Q1 2014$3,044,000
-45.8%
172,215
-25.7%
0.01%
-37.5%
Q4 2013$5,614,000
-2.9%
231,858
+42.2%
0.01%0.0%
Q3 2013$5,779,000
+277.2%
163,100
+66.2%
0.01%
+166.7%
Q2 2013$1,532,00098,1460.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2016
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders